Axel Woschina

Title: The Innovative Contributions of Axel Woschina

Introduction

Axel Woschina is a notable inventor based in Poing, Germany. He has made significant contributions to the field of pharmaceuticals, particularly through his innovative work on Lifibrol. With a total of 3 patents to his name, Woschina continues to push the boundaries of pharmaceutical development.

Latest Patents

One of Woschina's latest patents is titled "Method for the production of E-1-4'- (2-Dimethylaminoethoxy) - Lifibrol and its use." This patent describes a new modification of Lifibrol, which has a melting point ranging from 132°C to 138°C, particularly between 134°C and 136°C. The modification is characterized by a primary peak in its IR spectrum at a wave number of 3,200-3,400, preferably at 3,250-3,350. This new modification, referred to as modification II, allows for excellent crystallization, making it suitable for large-scale industrial formulation into tablets of acceptable size and high stability.

Career Highlights

Woschina is currently associated with Klinge Pharma GmbH, where he applies his expertise in pharmaceutical innovation. His work has been instrumental in advancing the production processes of important pharmaceutical compounds.

Collaborations

Woschina collaborates with talented professionals in his field, including Helmut Grill and Artur Burger. Their combined efforts contribute to the success of their projects and the advancement of pharmaceutical technologies.

Conclusion

Axel Woschina's innovative work in the pharmaceutical industry exemplifies the impact of dedicated inventors on healthcare advancements. His contributions, particularly in the development of Lifibrol, highlight the importance of innovation in creating effective pharmaceutical solutions.